242 related articles for article (PubMed ID: 16585990)
1. Clinicopathological analysis of 1571 cutaneous malignant melanomas in Valencia, Spain: factors related to tumour thickness.
Nagore E; Oliver V; Botella-Estrada R; Moreno-Picot S; Guillén C; Fortea JM
Acta Derm Venereol; 2006; 86(1):50-6. PubMed ID: 16585990
[TBL] [Abstract][Full Text] [Related]
2. Time trends in tumour thickness vary in subgroups: analysis of 6475 patients by age, tumour site and melanoma subtype.
Baumert J; Schmidt M; Giehl KA; Volkenandt M; Plewig G; Wendtner C; Schmid-Wendtner MH
Melanoma Res; 2009 Feb; 19(1):24-30. PubMed ID: 19430403
[TBL] [Abstract][Full Text] [Related]
3. Changes from mid-1980s to late 1990s among clinical and demographic correlates of melanoma thickness.
Crocetti E; Carli P
Eur J Dermatol; 2003; 13(1):72-5. PubMed ID: 12609787
[TBL] [Abstract][Full Text] [Related]
4. Comparison between familial and sporadic cutaneous melanoma in Valencia, Spain.
Nagore E; Botella-Estrada R; Garcia-Casado Z; Requena C; Serra-Guillen C; Llombart B; Sanmartin O; Guillen C
J Eur Acad Dermatol Venereol; 2008 Aug; 22(8):931-6. PubMed ID: 18355200
[TBL] [Abstract][Full Text] [Related]
5. Symptoms and signs of primary melanoma: important indicators of Breslow depth.
Negin BP; Riedel E; Oliveria SA; Berwick M; Coit DG; Brady MS
Cancer; 2003 Jul; 98(2):344-8. PubMed ID: 12872355
[TBL] [Abstract][Full Text] [Related]
6. Factors associated with a high tumour thickness in patients with melanoma.
Baumert J; Plewig G; Volkenandt M; Schmid-Wendtner MH
Br J Dermatol; 2007 May; 156(5):938-44. PubMed ID: 17381454
[TBL] [Abstract][Full Text] [Related]
7. Malignant melanoma of the foot. A clinicopathological study of 125 primary cutaneous malignant melanomas.
Søndergaard K; Olsen G
Acta Pathol Microbiol Scand A; 1980 Sep; 88(5):275-83. PubMed ID: 7468216
[TBL] [Abstract][Full Text] [Related]
8. The impact of factors beyond Breslow depth on predicting sentinel lymph node positivity in melanoma.
Paek SC; Griffith KA; Johnson TM; Sondak VK; Wong SL; Chang AE; Cimmino VM; Lowe L; Bradford CR; Rees RS; Sabel MS
Cancer; 2007 Jan; 109(1):100-8. PubMed ID: 17146784
[TBL] [Abstract][Full Text] [Related]
9. Lymphatic invasion identified by monoclonal antibody D2-40, younger age, and ulceration: predictors of sentinel lymph node involvement in primary cutaneous melanoma.
Niakosari F; Kahn HJ; McCready D; Ghazarian D; Rotstein LE; Marks A; Kiss A; From L
Arch Dermatol; 2008 Apr; 144(4):462-7. PubMed ID: 18427039
[TBL] [Abstract][Full Text] [Related]
10. A retrospective histological study of 669 cases of primary cutaneous malignant melanoma in clinical stage I. 3. The relation between the tumour-associated lymphocyte infiltration and age and sex, tumour cell type, pigmentation, cellular atypia, mitotic count, depth of invasion, ulceration, tumour type and prognosis.
Larsen TE; Grude TH
Acta Pathol Microbiol Scand A; 1978 Nov; 86A(6):523-30. PubMed ID: 716913
[TBL] [Abstract][Full Text] [Related]
11. Site, histological type, and thickness of primary cutaneous malignant melanoma in western Netherlands since 1980.
van der Spek-Keijser LM; van der Rhee HJ; Tóth G; Van Westering R; Bruijn JA; Coebergh JW
Br J Dermatol; 1997 Apr; 136(4):565-71. PubMed ID: 9155959
[TBL] [Abstract][Full Text] [Related]
12. Is head and neck melanoma a distinct entity? A clinical registry-based comparative study in 5702 patients with melanoma.
Hoersch B; Leiter U; Garbe C
Br J Dermatol; 2006 Oct; 155(4):771-7. PubMed ID: 16965427
[TBL] [Abstract][Full Text] [Related]
13. Invasive cutaneous malignant melanoma in Sweden, 1990-1999. A prospective, population-based study of survival and prognostic factors.
Lindholm C; Andersson R; Dufmats M; Hansson J; Ingvar C; Möller T; Sjödin H; Stierner U; Wagenius G;
Cancer; 2004 Nov; 101(9):2067-78. PubMed ID: 15372475
[TBL] [Abstract][Full Text] [Related]
14. Prognostic factors of thin cutaneous melanoma: an analysis of the central malignant melanoma registry of the german dermatological society.
Leiter U; Buettner PG; Eigentler TK; Garbe C
J Clin Oncol; 2004 Sep; 22(18):3660-7. PubMed ID: 15302905
[TBL] [Abstract][Full Text] [Related]
15. A ten-year analysis of demographic trends for cutaneous melanoma: analysis of 2501 cases treated at the University Department of Dermatology in Vienna (1990-1999).
Kittler H; Binder M; Wolff K; Pehamberger H
Wien Klin Wochenschr; 2001 Apr; 113(9):321-7. PubMed ID: 11388077
[TBL] [Abstract][Full Text] [Related]
16. Thin primary cutaneous melanomas: associated detection patterns, lesion characteristics, and patient characteristics.
Schwartz JL; Wang TS; Hamilton TA; Lowe L; Sondak VK; Johnson TM
Cancer; 2002 Oct; 95(7):1562-8. PubMed ID: 12237926
[TBL] [Abstract][Full Text] [Related]
17. The complex relationships between sentinel node positivity, patient age, and primary tumor desmoplasia: analysis of 2303 melanoma patients treated at a single center.
Sassen S; Shaw HM; Colman MH; Scolyer RA; Thompson JF
Ann Surg Oncol; 2008 Feb; 15(2):630-7. PubMed ID: 18080717
[TBL] [Abstract][Full Text] [Related]
18. Cutaneous melanomas associated with nevi.
Bevona C; Goggins W; Quinn T; Fullerton J; Tsao H
Arch Dermatol; 2003 Dec; 139(12):1620-4; discussion 1624. PubMed ID: 14676081
[TBL] [Abstract][Full Text] [Related]
19. Prognostic factors of cutaneous melanoma in relation to metastasis at the sentinel lymph node: a case-controlled study.
Sartore L; Papanikolaou GE; Biancari F; Mazzoleni F
Int J Surg; 2008 Jun; 6(3):205-9. PubMed ID: 18417434
[TBL] [Abstract][Full Text] [Related]
20. Acral lentiginous melanoma: a clinicoprognostic study of 126 cases.
Phan A; Touzet S; Dalle S; Ronger-Savlé S; Balme B; Thomas L
Br J Dermatol; 2006 Sep; 155(3):561-9. PubMed ID: 16911282
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
